Deletion of vanilloid receptor 1-expressing primary afferent neurons for pain control

Laszlo Karai1, Dorothy C Brown, Andrew J Mannes

  • 1National Institute of Dental and Craniofacial Research, Bethesda, Maryland 20892, USA.

Insights

Targeting pain-sensing neurons with resiniferatoxin (RTX) offers a novel therapeutic strategy. This approach selectively eliminates nociceptive neurons, effectively managing severe pain without compromising other sensory or motor functions.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Management

Background:

  • Current pain management strategies often have inadequate efficacy or debilitating side effects.
  • Selective elimination of nociceptive neurons presents a promising therapeutic avenue for severe pain.
  • Transient receptor potential cation channel, subfamily V, member 1 (TRPV1) is highly expressed in nociceptive neurons.

Purpose of the Study:

  • To investigate the therapeutic potential of selectively ablating nociceptive neurons using TRPV1 activation.
  • To evaluate the efficacy of resiniferatoxin (RTX) in controlling various types of severe pain.

Main Methods:

  • Administration of RTX, a potent TRPV1 agonist, to neuronal perikarya in preclinical models (rats, dogs) and human cell cultures.
  • Assessment of pain reduction, inflammatory markers, and preservation of other sensory and motor functions.
  • Evaluation of RTX's effect on nociceptive nerve endings for postoperative pain control.

Main Results:

  • RTX selectively ablated nociceptive neurons by inducing calcium cytotoxicity via TRPV1 channel opening.
  • Successful blockade of inflammatory hyperalgesia, neurogenic inflammation, cancer pain, and arthritic pain in animal models.
  • Preservation of touch, proprioception, mechanosensation, and motor function.
  • Reversible analgesia achieved through transient disruption of nociceptive nerve endings in postoperative pain models.
  • Selective calcium increase in vanilloid-sensitive neurons in human dorsal root ganglion cultures.

Conclusions:

  • Selective deletion of nociceptive neurons or their terminals is a viable and broadly applicable strategy for pain management.
  • TRPV1-targeted therapy with RTX demonstrates significant potential for treating diverse and severe pain conditions.
  • This approach offers a new paradigm for pain control with preserved essential sensory and motor functions.

Related Concept Videos

Thermosensation01:43

Thermosensation

Peripheral thermosensation is the perception of external temperature. A change in temperature (on the surface of the skin and other tissues) is detected by a family of temperature-sensitive ion channels called Transient Receptor Potential, or TRP, receptors. These receptors are located on free nerve endings. Those detecting cold temperatures are closer to the surface of the skin than the nerve endings detecting warmth. These thermoTRP channels, while temperature selective, have relatively...
29.7K
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
28.4K
Local Anesthetics: Differential Sensitivity of Nerve Fibers01:24

Local Anesthetics: Differential Sensitivity of Nerve Fibers

Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
1.8K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.4K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.4K
Pain01:20

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
2.1K